Replimune (REPL) Sof foyda bo'yicha sotuv rentabelligi

Replimune Group, Inc. (REPL) tovar belgisi

Replimune Group, Inc. (REPL) dori vositasi tasdiqlanguncha hech qanday daromad keltirmaydi va narxlarni belgilash imkoniyatiga ega emas. Dori sinovlari tashqi CROlarga topshirilgan, garchi ishlab chiqarishning bir qismi mahalliy tarzda amalga oshirilsa-da. GURU.Markets platformasidagi sof foyda marjasi grafigini tahlil qilib, 0.00 qiymati joriy ko'rsatkichga mos kelishini ko'ramiz. Biroq, kapital talablari va klinik sinovlarning muvaffaqiyatsiz tugash xavfi tufayli Replimune Group, Inc. (REPL) moliyaviy barqarorligi xavf ostida qolmoqda.

REPL: Replimune Inc. Kompaniyaning sof rentabelligi 04.07.2022 - 19.11.2026

Replimune Group, Inc. kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:replimune.com - REPL
Replimune Corp yetakchi tovari

Investorlar xavfsizlik zaxirasini sof foyda marjasi orqali baholaydilar, bu esa savdolarni yakuniy daromadga aylantirish samaradorligini belgilaydi. Tijoriy mahsulotlarsiz tadqiqot va ishlanmalarga ( R&D ) kapital sarflayotgan Replimune Group, Inc. (REPL) uchun ushbu grafikdagi sof foyda marjasi chuqur operatsion zararni aks ettiradi va uning klinik sinovlar bosqichidagi yuqori xavfli biotexnologiya kompaniyasi maqomini tasdiqlaydi.

Raqobatchilar tahlili

NantKwest (IBRX) - Sof marja|Sof marja Immunocore PLC (IMCR)|Sof foyda bo'yicha sotuv rentabelligi JANX|RCUS - Sof foyda bo'yicha marjinallik|Sof foyda bo'yicha sotuv rentabelligi ZYME (Zymeworks Corp)|Kompaniyaning sof rentabelligi TNGX|Sotuvning sof marjinal rentabelligi IOVA (Iovance Biotherapeutics, Inc.)|Sof foyda normasi IMTX|xencor.com - Sotuvning sof marjinal rentabelligi|Sof marja Compass Therapeutics Corp|Lyell Immunopharma (LYEL) - Sof marja|Innate Pharma S.A. - Sof foyda normasi|PYXS (Pyxis) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi cgen.com|Sof marja IO Biotech (IOBT)|STRO: Sof foyda marjasi|MiNK Therapeutics Inc. - Sof foyda bo'yicha sotuv rentabelligi|werewolftx.com (HOWL) - Sof marja|Immix Biopharma Inc. - Sotuvning sof marjinal rentabelligi|ALXO - Sotuvning sof marjinal rentabelligi|CUE: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi PDSB|Sof marja Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi LIMN|Sotuvning sof marjinal rentabelligi Lava Tx (LVTX)|Sotuvning sof marjinal rentabelligi NXTC (NextCure Corporation)|Sof foyda normasi LPTX|INTS - Sof marja|Kompaniya sotuv marjasi Sensei Biotherapeutics Inc SNSE|TOVX: Sotuvning sof marjinal rentabelligi|Sof marja Gritstone Bio (GRTS)|KA (Kineta Corp) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi NEXI (NexImmune Corp)|Sotuvning sof marjinal rentabelligi TSBX|VCNX (Vaccinex, Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi HARP (Harpoon Therapeutics, Inc.)